25 XP   0   0   10

Arcellx Inc
Buy, Hold or Sell?

Let's analyse Arcellx together

PenkeI guess you are interested in Arcellx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arcellx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.

Quick analysis of Arcellx (30 sec.)










What can you expect buying and holding a share of Arcellx? (30 sec.)

How much money do you get?

How much money do you get?
$1.54
When do you have the money?
1 year
How often do you get paid?
15.4%

What is your share worth?

Current worth
$9.19
Expected worth in 1 year
$14.50
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
$6.85
Return On Investment
13.0%

For what price can you sell your share?

Current Price per Share
$52.82
Expected price per share
$48.38 - $74.57
How sure are you?
50%

1. Valuation of Arcellx (5 min.)




Live pricePrice per Share (EOD)

$52.82

Intrinsic Value Per Share

$14.73 - $17.68

Total Value Per Share

$23.92 - $26.87

2. Growth of Arcellx (5 min.)




Is Arcellx growing?

Current yearPrevious yearGrowGrow %
How rich?$485.3m$244.6m$92.5m27.4%

How much money is Arcellx making?

Current yearPrevious yearGrowGrow %
Making money-$17.5m-$49m$31.4m179.0%
Net Profit Margin-137.3%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Arcellx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#114 / 1010

Most Revenue
#203 / 1010

Most Profit
#669 / 1010

Most Efficient
#592 / 1010

What can you expect buying and holding a share of Arcellx? (5 min.)

Welcome investor! Arcellx's management wants to use your money to grow the business. In return you get a share of Arcellx.

What can you expect buying and holding a share of Arcellx?

First you should know what it really means to hold a share of Arcellx. And how you can make/lose money.

Speculation

The Price per Share of Arcellx is $52.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arcellx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arcellx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.19. Based on the TTM, the Book Value Change Per Share is $1.33 per quarter. Based on the YOY, the Book Value Change Per Share is $1.55 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arcellx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.380.7%-0.33-0.6%-0.93-1.8%-0.50-0.9%-0.50-0.9%
Usd Book Value Change Per Share4.157.9%1.332.5%1.552.9%0.711.3%0.711.3%
Usd Dividend Per Share1.542.9%0.380.7%0.000.0%0.120.2%0.120.2%
Usd Total Gains Per Share5.6910.8%1.713.2%1.552.9%0.831.6%0.831.6%
Usd Price Per Share55.50-38.45-20.46-18.13-18.13-
Price to Earnings Ratio36.92--1.87--6.58--2.60--2.60-
Price-to-Total Gains Ratio9.75--52.17--13.11--32.64--32.64-
Price to Book Ratio6.04-6.05-4.63-3.29-3.29-
Price-to-Total Gains Ratio9.75--52.17--13.11--32.64--32.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share52.82
Number of shares18
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.380.12
Usd Book Value Change Per Share1.330.71
Usd Total Gains Per Share1.710.83
Gains per Quarter (18 shares)30.8214.87
Gains per Year (18 shares)123.2959.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1289611395149
25519123617102108
38328735926153167
411138248234204226
513847860543255285
616657472851306344
719466985160356403
822176597469407462
9249860109777458521
10277956122086509580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.012.00.07.7%1.012.00.07.7%1.012.00.07.7%
Book Value Change Per Share2.02.00.050.0%4.06.02.033.3%4.07.02.030.8%4.07.02.030.8%4.07.02.030.8%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.011.015.4%2.00.011.015.4%2.00.011.015.4%
Total Gains per Share2.02.00.050.0%4.06.02.033.3%4.07.02.030.8%4.07.02.030.8%4.07.02.030.8%

Fundamentals of Arcellx

About Arcellx Inc

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-04-09 17:13:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Arcellx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arcellx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Net Profit Margin of 31.4% means that $0.31 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arcellx Inc:

  • The MRQ is 31.4%. The company is making a huge profit. +2
  • The TTM is -137.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ31.4%TTM-137.3%+168.7%
TTM-137.3%YOY--137.3%
TTM-137.3%5Y-42.2%-95.1%
5Y-42.2%10Y-42.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.4%-200.1%+231.5%
TTM-137.3%-216.8%+79.5%
YOY--288.3%+288.3%
5Y-42.2%-449.1%+406.9%
10Y-42.2%-605.5%+563.3%
1.1.2. Return on Assets

Shows how efficient Arcellx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • 2.4% Return on Assets means that Arcellx generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arcellx Inc:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is -3.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.4%TTM-3.0%+5.4%
TTM-3.0%YOY-15.5%+12.4%
TTM-3.0%5Y-12.7%+9.6%
5Y-12.7%10Y-12.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%-13.3%+15.7%
TTM-3.0%-12.8%+9.8%
YOY-15.5%-11.7%-3.8%
5Y-12.7%-13.9%+1.2%
10Y-12.7%-15.7%+3.0%
1.1.3. Return on Equity

Shows how efficient Arcellx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • 4.1% Return on Equity means Arcellx generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arcellx Inc:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ4.1%TTM-6.9%+11.0%
TTM-6.9%YOY-20.8%+13.8%
TTM-6.9%5Y-8.5%+1.6%
5Y-8.5%10Y-8.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%-16.9%+21.0%
TTM-6.9%-16.1%+9.2%
YOY-20.8%-15.1%-5.7%
5Y-8.5%-19.3%+10.8%
10Y-8.5%-20.2%+11.7%

1.2. Operating Efficiency of Arcellx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arcellx is operating .

  • Measures how much profit Arcellx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • An Operating Margin of 23.8% means the company generated $0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arcellx Inc:

  • The MRQ is 23.8%. The company is operating efficient. +1
  • The TTM is -153.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ23.8%TTM-153.0%+176.7%
TTM-153.0%YOY--153.0%
TTM-153.0%5Y-47.1%-105.9%
5Y-47.1%10Y-47.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.8%-296.2%+320.0%
TTM-153.0%-232.5%+79.5%
YOY--298.2%+298.2%
5Y-47.1%-492.1%+445.0%
10Y-47.1%-632.4%+585.3%
1.2.2. Operating Ratio

Measures how efficient Arcellx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arcellx Inc:

  • The MRQ is 0.762. The company is efficient in keeping operating costs low. +1
  • The TTM is 2.662. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.762TTM2.662-1.900
TTM2.662YOY-+2.662
TTM2.6625Y0.819+1.843
5Y0.81910Y0.8190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7623.231-2.469
TTM2.6623.310-0.648
YOY-3.890-3.890
5Y0.8195.739-4.920
10Y0.8197.876-7.057

1.3. Liquidity of Arcellx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arcellx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.06 means the company has $6.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arcellx Inc:

  • The MRQ is 6.059. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.978. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.059TTM3.978+2.081
TTM3.978YOY8.624-4.646
TTM3.9785Y5.961-1.982
5Y5.96110Y5.9610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0593.890+2.169
TTM3.9784.173-0.195
YOY8.6245.344+3.280
5Y5.9616.126-0.165
10Y5.9616.448-0.487
1.3.2. Quick Ratio

Measures if Arcellx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Quick Ratio of 8.54 means the company can pay off $8.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arcellx Inc:

  • The MRQ is 8.537. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.675. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.537TTM5.675+2.862
TTM5.675YOY12.672-6.996
TTM5.6755Y8.365-2.690
5Y8.36510Y8.3650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5373.514+5.023
TTM5.6753.998+1.677
YOY12.6725.380+7.292
5Y8.3656.105+2.260
10Y8.3656.404+1.961

1.4. Solvency of Arcellx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arcellx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arcellx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that Arcellx assets are financed with 41.2% credit (debt) and the remaining percentage (100% - 41.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arcellx Inc:

  • The MRQ is 0.412. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.505. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.412TTM0.505-0.093
TTM0.505YOY0.224+0.281
TTM0.5055Y0.991-0.486
5Y0.99110Y0.9910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4120.339+0.073
TTM0.5050.336+0.169
YOY0.2240.271-0.047
5Y0.9910.366+0.625
10Y0.9910.389+0.602
1.4.2. Debt to Equity Ratio

Measures if Arcellx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 70.0% means that company has $0.70 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arcellx Inc:

  • The MRQ is 0.700. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.046. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.700TTM1.046-0.346
TTM1.046YOY0.311+0.734
TTM1.0465Y0.417+0.628
5Y0.41710Y0.4170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7000.388+0.312
TTM1.0460.402+0.644
YOY0.3110.335-0.024
5Y0.4170.426-0.009
10Y0.4170.461-0.044

2. Market Valuation of Arcellx Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arcellx generates.

  • Above 15 is considered overpriced but always compare Arcellx to the Biotechnology industry mean.
  • A PE ratio of 36.92 means the investor is paying $36.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arcellx Inc:

  • The EOD is 35.133. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.916. Based on the earnings, the company is overpriced. -1
  • The TTM is -1.873. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD35.133MRQ36.916-1.783
MRQ36.916TTM-1.873+38.789
TTM-1.873YOY-6.576+4.703
TTM-1.8735Y-2.600+0.727
5Y-2.60010Y-2.6000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD35.133-2.264+37.397
MRQ36.916-2.629+39.545
TTM-1.873-2.680+0.807
YOY-6.576-4.145-2.431
5Y-2.600-6.257+3.657
10Y-2.600-6.254+3.654
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arcellx Inc:

  • The EOD is 13.166. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.833. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -6.043. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD13.166MRQ13.833-0.668
MRQ13.833TTM-6.043+19.877
TTM-6.043YOY-11.214+5.171
TTM-6.0435Y-5.310-0.733
5Y-5.31010Y-5.3100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.166-2.973+16.139
MRQ13.833-3.333+17.166
TTM-6.043-3.553-2.490
YOY-11.214-5.605-5.609
5Y-5.310-8.376+3.066
10Y-5.310-8.865+3.555
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arcellx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.04 means the investor is paying $6.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arcellx Inc:

  • The EOD is 5.745. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.037. Based on the equity, the company is overpriced. -1
  • The TTM is 6.049. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.745MRQ6.037-0.292
MRQ6.037TTM6.049-0.012
TTM6.049YOY4.634+1.415
TTM6.0495Y3.287+2.762
5Y3.28710Y3.2870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.7451.896+3.849
MRQ6.0372.115+3.922
TTM6.0492.093+3.956
YOY4.6342.884+1.750
5Y3.2873.542-0.255
10Y3.2873.916-0.629
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arcellx Inc.

3.1. Institutions holding Arcellx Inc

Institutions are holding 91.079% of the shares of Arcellx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Perceptive Advisors LLC8.69325.6303454480957883114.5949
2023-12-31FMR Inc8.37640.01874379169-158183-3.4862
2023-12-31NEA Management Company, LLC7.163813.8534374526200
2023-12-31Paradigm Biocapital Advisors LP6.99819.5066365862470550223.89
2023-12-31SR ONE CAPITAL MANAGEMENT, LP6.018873.32883146630-800000-20.2705
2023-12-31BlackRock Inc5.77380.0043301853831087611.4813
2023-12-31Suvretta Capital Management, LLC4.65956.11242435974-433993-15.1219
2023-12-31Vanguard Group Inc3.94380.00252061819232621.1411
2023-12-31State Street Corporation3.3930.00481773839-240406-11.9353
2023-12-31Cormorant Asset Management, LLC3.25174.5061700000-450000-20.9302
2023-12-31HHG PLC2.94220.05091538210-237228-13.3617
2023-12-31T. Rowe Price Associates, Inc.2.41040.0094126018032330934.5094
2023-12-31Lord, Abbett & Co LLC2.28880.23851196567985308.9733
2023-12-31T. Rowe Price Investment Management,Inc.1.76430.0333922399122211.3427
2023-12-31Geode Capital Management, LLC1.50230.0046785402463486.2713
2023-12-31Deep Track Capital, LP1.3871.34417251457251450
2023-12-31Goldman Sachs Group Inc1.36070.0035711386-163472-18.6855
2023-12-31Morgan Stanley - Brokerage Accounts1.28780.0033673285568027539.6521
2023-12-31JPMorgan Chase & Co1.15130.0032601913380146.7413
2023-12-31Samsara BioCapital, LLC0.88073.9755460441-153480-25
Total 75.2476118.634139339592+793303+2.0%

3.2. Funds holding Arcellx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Select Biotechnology2.42791.7015126930100
2024-02-29Vanguard Total Stock Mkt Idx Inv2.24670.0051174564-3777-0.3205
2024-02-29SPDR® S&P Biotech ETF2.01290.87471052335196801.9058
2024-02-29iShares Russell 2000 ETF1.77420.0979927554-152-0.0164
2024-01-31Lord Abbett Developing Growth A1.3281.8566694255-8818-1.2542
2023-12-31Janus Henderson Global Life Sciences0.90710.5374474254-28245-5.6209
2023-12-31Janus Henderson Global Life Sciences D0.90710.5348474254-28245-5.6209
2023-12-31US Small-Cap Growth II Equity Comp0.90310.105547212210020526.9428
2023-12-31T. Rowe Price New Horizons0.90310.105947212210020526.9428
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.89860.030346978920610.4406
2024-01-31Fidelity Select Health Care0.86070.363845000000
2023-09-30UBS: US Equity Small Cap Growth0.84990.742444430900
2023-12-31Fidelity Small Cap Growth0.75340.3828393884101002.6317
2023-12-31Fidelity Small Cap Index0.72960.083338144186482.3198
2023-12-31T. Rowe Price Small-Cap Stock0.72250.2215377700-600-0.1586
2023-12-31T. Rowe Price US Small-Cap Core Equity0.72250.221377700-600-0.1586
2024-02-29Janus Henderson Glb Life Scn I2 USD0.70650.61136935697522.7119
2023-12-31Janus Selection Global Life Science AUSD0.6790.5327354961-27661-7.2293
2024-02-29iShares Russell 2000 Growth ETF0.64520.1956337322-392-0.1161
2023-12-31Fidelity Series Small Cap Opps0.59810.3182312700-5800-1.821
Total 21.57619.521911279923+146361+1.3%

3.3. Insider Transactions

Insiders are holding 12.965% of the shares of Arcellx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01Rami ElghandourSELL2308667.09
2024-03-26Christopher HeerySELL545069.11
2024-03-22Christopher HeerySELL4136570.18
2024-03-21Jill CarrollSELL50426370.55
2024-03-18Michelle GilsonSELL682569.34
2024-03-15Olivia C. WareSELL900070.4
2024-02-12Christopher HeerySELL296764.46
2024-02-08Christopher HeerySELL345662.29
2024-01-04Christopher HeerySELL759855.27
2024-01-04Michelle GilsonSELL851455.27
2023-08-04Christopher HeerySELL300035.38
2023-07-03Christopher HeerySELL300031.75
2023-05-31Jill CarrollSELL31516441.5
2023-05-31Rami ElghandourSELL260044.27
2023-05-24Michelle GilsonSELL870442.46
2023-05-11Jill CarrollSELL63841745.01
2023-05-11Sr One Capital Management, LlcSELL101283345.01
2023-05-09Christopher HeerySELL50045
2023-05-05Christopher HeerySELL120045
2023-05-03Christopher HeerySELL300043.44

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Arcellx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.1531.328+213%1.546+169%0.707+487%0.707+487%
Book Value Per Share--9.1936.387+44%4.635+98%2.785+230%2.785+230%
Current Ratio--6.0593.978+52%8.624-30%5.961+2%5.961+2%
Debt To Asset Ratio--0.4120.505-18%0.224+84%0.991-58%0.991-58%
Debt To Equity Ratio--0.7001.046-33%0.311+125%0.417+68%0.417+68%
Dividend Per Share--1.5380.385+300%0.002+68719%0.119+1192%0.119+1192%
Eps--0.376-0.335+189%-0.930+347%-0.497+232%-0.497+232%
Free Cash Flow Per Share--1.0030.881+14%-0.481+148%0.024+4033%0.024+4033%
Free Cash Flow To Equity Per Share--4.5752.203+108%0.715+540%1.034+342%1.034+342%
Gross Profit Margin--1.0361.009+3%1.000+4%1.003+3%1.003+3%
Intrinsic Value_10Y_max--17.675--------
Intrinsic Value_10Y_min--14.726--------
Intrinsic Value_1Y_max--0.389--------
Intrinsic Value_1Y_min--0.382--------
Intrinsic Value_3Y_max--2.223--------
Intrinsic Value_3Y_min--2.101--------
Intrinsic Value_5Y_max--5.327--------
Intrinsic Value_5Y_min--4.853--------
Market Cap2788716412.000-5%2930211300.0002030161261.500+44%1080350427.500+171%957080519.692+206%957080519.692+206%
Net Profit Margin--0.314-1.373+537%-+100%-0.422+234%-0.422+234%
Operating Margin--0.238-1.530+744%-+100%-0.471+298%-0.471+298%
Operating Ratio--0.7622.662-71%-+100%0.819-7%0.819-7%
Pb Ratio5.745-5%6.0376.0490%4.634+30%3.287+84%3.287+84%
Pe Ratio35.133-5%36.916-1.873+105%-6.576+118%-2.600+107%-2.600+107%
Price Per Share52.820-5%55.50038.453+44%20.463+171%18.128+206%18.128+206%
Price To Free Cash Flow Ratio13.166-5%13.833-6.043+144%-11.214+181%-5.310+138%-5.310+138%
Price To Total Gains Ratio9.282-5%9.752-52.169+635%-13.112+234%-32.640+435%-32.640+435%
Quick Ratio--8.5375.675+50%12.672-33%8.365+2%8.365+2%
Return On Assets--0.024-0.030+226%-0.155+743%-0.127+627%-0.127+627%
Return On Equity--0.041-0.069+269%-0.208+608%-0.085+308%-0.085+308%
Total Gains Per Share--5.6911.712+232%1.548+268%0.826+589%0.826+589%
Usd Book Value--485380000.000337223000.000+44%244696250.000+98%147015923.077+230%147015923.077+230%
Usd Book Value Change Per Share--4.1531.328+213%1.546+169%0.707+487%0.707+487%
Usd Book Value Per Share--9.1936.387+44%4.635+98%2.785+230%2.785+230%
Usd Dividend Per Share--1.5380.385+300%0.002+68719%0.119+1192%0.119+1192%
Usd Eps--0.376-0.335+189%-0.930+347%-0.497+232%-0.497+232%
Usd Free Cash Flow--52955000.00046536250.000+14%-25395000.000+148%1281230.769+4033%1281230.769+4033%
Usd Free Cash Flow Per Share--1.0030.881+14%-0.481+148%0.024+4033%0.024+4033%
Usd Free Cash Flow To Equity Per Share--4.5752.203+108%0.715+540%1.034+342%1.034+342%
Usd Market Cap2788716412.000-5%2930211300.0002030161261.500+44%1080350427.500+171%957080519.692+206%957080519.692+206%
Usd Price Per Share52.820-5%55.50038.453+44%20.463+171%18.128+206%18.128+206%
Usd Profit--19844000.000-17590250.000+189%-49085500.000+347%-26212692.308+232%-26212692.308+232%
Usd Revenue--63148000.00027579750.000+129%-+100%8486076.923+644%8486076.923+644%
Usd Total Gains Per Share--5.6911.712+232%1.548+268%0.826+589%0.826+589%
 EOD+4 -4MRQTTM+33 -3YOY+27 -95Y+31 -510Y+31 -5

4.2. Fundamental Score

Let's check the fundamental score of Arcellx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1535.133
Price to Book Ratio (EOD)Between0-15.745
Net Profit Margin (MRQ)Greater than00.314
Operating Margin (MRQ)Greater than00.238
Quick Ratio (MRQ)Greater than18.537
Current Ratio (MRQ)Greater than16.059
Debt to Asset Ratio (MRQ)Less than10.412
Debt to Equity Ratio (MRQ)Less than10.700
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.024
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.321
Ma 20Greater thanMa 5059.426
Ma 50Greater thanMa 10064.238
Ma 100Greater thanMa 20060.441
OpenGreater thanClose54.540
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -38,99211,977-27,0152,879-24,136-15,206-39,34259,80820,466
Net Income  -38,99211,977-27,0153,161-23,854-15,482-39,33659,18019,844
EBIT  -40,0049,547-30,4577,201-23,256-22,053-45,30960,30814,999
EBITDA  -35,2879,730-25,5572,740-22,817-22,045-44,86260,58315,721
Operating Income  -40,0049,547-30,457897-29,560-15,302-44,86259,86114,999
Net Income from Continuing Operations  -38,99211,648-27,3443,490-23,854-15,482-39,33659,18019,844



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets825,132
Total Liabilities339,752
Total Stockholder Equity485,380
 As reported
Total Liabilities 339,752
Total Stockholder Equity+ 485,380
Total Assets = 825,132

Assets

Total Assets825,132
Total Current Assets716,363
Long-term Assets96,995
Total Current Assets
Cash And Cash Equivalents 394,583
Short-term Investments 307,434
Other Current Assets 14,346
Total Current Assets  (as reported)716,363
Total Current Assets  (calculated)716,363
+/-0
Long-term Assets
Property Plant Equipment 69,827
Long Term Investments 27,168
Other Assets 11,774
Long-term Assets  (as reported)96,995
Long-term Assets  (calculated)108,769
+/- 11,774

Liabilities & Shareholders' Equity

Total Current Liabilities118,238
Long-term Liabilities221,514
Total Stockholder Equity485,380
Total Current Liabilities
Short-term Debt 46,784
Accounts payable 2,619
Other Current Liabilities 18,302
Total Current Liabilities  (as reported)118,238
Total Current Liabilities  (calculated)67,705
+/- 50,533
Long-term Liabilities
Capital Lease Obligations 97,625
Long-term Liabilities  (as reported)221,514
Long-term Liabilities  (calculated)97,625
+/- 123,889
Total Stockholder Equity
Common Stock52
Retained Earnings -389,480
Accumulated Other Comprehensive Income 547
Other Stockholders Equity 874,261
Total Stockholder Equity (as reported)485,380
Total Stockholder Equity (calculated)485,380
+/-0
Other
Capital Stock52
Cash and Short Term Investments 702,017
Common Stock Shares Outstanding 52,280
Current Deferred Revenue50,533
Liabilities and Stockholders Equity 825,132
Net Debt -296,958
Net Invested Capital 485,380
Net Working Capital 598,125
Property Plant and Equipment Gross 75,080
Short Long Term Debt Total 97,625



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
57,694
0
0
144,963
128,782
243,390
375,326
337,327
313,817
622,943
623,528
614,218
825,132
825,132614,218623,528622,943313,817337,327375,326243,390128,782144,9630057,694
   > Total Current Assets 
49,357
0
0
134,139
112,809
220,903
325,747
290,305
266,863
571,367
558,070
491,456
716,363
716,363491,456558,070571,367266,863290,305325,747220,903112,809134,1390049,357
       Cash And Cash Equivalents 
46,596
0
0
70,027
104,617
127,160
164,540
56,763
64,179
274,892
303,665
126,119
394,583
394,583126,119303,665274,89264,17956,763164,540127,160104,61770,0270046,596
       Short-term Investments 
0
0
0
61,155
73,784
83,769
142,446
224,018
190,656
258,701
202,819
313,597
307,434
307,434313,597202,819258,701190,656224,018142,44683,76973,78461,155000
       Net Receivables 
0
0
0
0
0
0
0
0
0
21,230
29,431
31,480
0
031,48029,43121,230000000000
       Other Current Assets 
1,210
0
0
1,649
2,049
9,974
18,761
9,524
12,028
16,544
22,155
20,260
14,346
14,34620,26022,15516,54412,0289,52418,7619,9742,0491,649001,210
   > Long-term Assets 
8,337
0
0
10,824
15,973
22,487
49,579
47,022
46,954
44,066
51,671
109,884
96,995
96,995109,88451,67144,06646,95447,02249,57922,48715,97310,824008,337
       Property Plant Equipment 
4,900
0
0
6,781
10,318
13,375
37,109
39,003
39,890
44,066
51,671
66,924
69,827
69,82766,92451,67144,06639,89039,00337,10913,37510,3186,781004,900
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
42,960
27,168
27,16842,96000000000000
       Other Assets 
3,437
0
0
0
5,655
9,112
12,470
8,019
7,064
7,510
13,787
12,878
11,774
11,77412,87813,7877,5107,0648,01912,4709,1125,6550003,437
> Total Liabilities 
121,414
0
0
248,758
250,297
21,799
59,370
101,043
108,863
319,226
329,861
348,090
339,752
339,752348,090329,861319,226108,863101,04359,37021,799250,297248,75800121,414
   > Total Current Liabilities 
5,271
0
0
13,261
14,845
16,808
32,053
44,777
56,693
166,057
156,114
173,149
118,238
118,238173,149156,114166,05756,69344,77732,05316,80814,84513,261005,271
       Short-term Debt 
0
0
0
0
0
370
2,313
30,603
35,961
40,241
44,156
54,868
46,784
46,78454,86844,15640,24135,96130,6032,31337000000
       Accounts payable 
504
0
0
1,583
1,333
1,874
7,556
2,962
9,053
4,532
5,693
7,185
2,619
2,6197,1855,6934,5329,0532,9627,5561,8741,3331,58300504
       Other Current Liabilities 
4,767
0
0
11,678
13,512
14,564
22,184
11,212
11,679
13,997
12,390
16,916
18,302
18,30216,91612,39013,99711,67911,21222,18414,56413,51211,678004,767
   > Long-term Liabilities 
116,143
0
0
235,497
235,452
4,991
27,317
56,266
52,170
153,169
173,747
174,941
221,514
221,514174,941173,747153,16952,17056,26627,3174,991235,452235,49700116,143
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
4,844
27,200
56,266
52,170
47,407
49,479
53,851
50,841
50,84153,85149,47947,40752,17056,26627,2004,84400000
       Other Liabilities 
1,882
0
0
0
1,896
0
0
0
0
0
0
0
0
000000001,8960001,882
       Long-term Liabilities Other 
19
0
0
206
178
4,991
27,317
4,624
0
153,169
173,747
0
0
00173,747153,16904,62427,3174,9911782060019
       Deferred Long Term Liability 
1,761
0
0
0
3,172
8,913
9,969
5,518
0
0
0
0
0
000005,5189,9698,9133,1720001,761
> Total Stockholder Equity
-63,720
0
0
-103,795
-121,515
221,591
315,956
236,284
204,954
303,717
293,667
266,128
485,380
485,380266,128293,667303,717204,954236,284315,956221,591-121,515-103,79500-63,720
   Common Stock
1
0
0
1
1
36
44
44
44
48
48
48
52
524848484444443611001
   Retained Earnings -389,480-409,324-369,988-346,134-318,790-279,798-194,587-162,496-130,111-109,44100-65,142
   Capital Surplus 
0
0
0
0
0
384,095
510,761
384,095
0
649,717
663,614
0
0
00663,614649,7170384,095510,761384,09500000
   Treasury Stock0000000000000
   Other Stockholders Equity 
1,421
0
0
5,650
8,615
137,111
136,098
179,110
523,921
649,717
663,607
675,404
874,261
874,261675,404663,607649,717523,921179,110136,098137,1118,6155,650001,421



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue110,319
Cost of Revenue-2,040
Gross Profit108,279108,279
 
Operating Income (+$)
Gross Profit108,279
Operating Expense-198,159
Operating Income-89,880-89,880
 
Operating Expense (+$)
Research Development133,849
Selling General Administrative66,350
Selling And Marketing Expenses-2,040
Operating Expense198,159198,159
 
Net Interest Income (+$)
Interest Income19,379
Interest Expense-3,842
Other Finance Cost-139
Net Interest Income15,398
 
Pretax Income (+$)
Operating Income-89,880
Net Interest Income15,398
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-70,027-109,733
EBIT - interestExpense = -93,722
-70,027
-66,848
Interest Expense3,842
Earnings Before Interest and Taxes (EBIT)-89,880-66,185
Earnings Before Interest and Taxes (EBITDA)-87,840
 
After tax Income (+$)
Income Before Tax-70,027
Tax Provision-663
Net Income From Continuing Ops-129,526-70,690
Net Income-70,690
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses200,199
Total Other Income/Expenses Net19,853-15,398
 

Technical Analysis of Arcellx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arcellx. The general trend of Arcellx is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arcellx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arcellx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 58.17 < 67.05 < 74.57.

The bearish price targets are: 51.37 > 48.92 > 48.38.

Tweet this
Arcellx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arcellx Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arcellx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arcellx Inc. The current macd is -3.74653549.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arcellx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arcellx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arcellx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Arcellx Inc Daily Moving Average Convergence/Divergence (MACD) ChartArcellx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arcellx Inc. The current adx is 38.91.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Arcellx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Arcellx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arcellx Inc. The current sar is 50.54.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Arcellx Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arcellx Inc. The current rsi is 32.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Arcellx Inc Daily Relative Strength Index (RSI) ChartArcellx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arcellx Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arcellx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Arcellx Inc Daily Stochastic Oscillator ChartArcellx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arcellx Inc. The current cci is -91.57095794.

Arcellx Inc Daily Commodity Channel Index (CCI) ChartArcellx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arcellx Inc. The current cmo is -38.61467401.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arcellx Inc Daily Chande Momentum Oscillator (CMO) ChartArcellx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arcellx Inc. The current willr is -83.01675978.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Arcellx Inc Daily Williams %R ChartArcellx Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arcellx Inc.

Arcellx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arcellx Inc. The current atr is 2.75213908.

Arcellx Inc Daily Average True Range (ATR) ChartArcellx Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arcellx Inc. The current obv is 7,185,536.

Arcellx Inc Daily On-Balance Volume (OBV) ChartArcellx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arcellx Inc. The current mfi is 10.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Arcellx Inc Daily Money Flow Index (MFI) ChartArcellx Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arcellx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Arcellx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.321
Ma 20Greater thanMa 5059.426
Ma 50Greater thanMa 10064.238
Ma 100Greater thanMa 20060.441
OpenGreater thanClose54.540
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arcellx with someone you think should read this too:
  • Are you bullish or bearish on Arcellx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arcellx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arcellx Inc.

Receive notifications about Arcellx Inc in your mailbox!